129 related articles for article (PubMed ID: 35779293)
1. Association between microRNAs and chemoresistance in pancreatic cancer: Current knowledge, new insights, and forthcoming perspectives.
Rahnama N; Jahangir M; Alesaeid S; Kahrizi MS; Adili A; Mohammed RN; Aslaminabad R; Akbari M; Özgönül AM
Pathol Res Pract; 2022 Aug; 236():153982. PubMed ID: 35779293
[TBL] [Abstract][Full Text] [Related]
2. The underlying mechanisms of non-coding RNAs in the chemoresistance of pancreatic cancer.
Xiong G; Feng M; Yang G; Zheng S; Song X; Cao Z; You L; Zheng L; Hu Y; Zhang T; Zhao Y
Cancer Lett; 2017 Jul; 397():94-102. PubMed ID: 28254409
[TBL] [Abstract][Full Text] [Related]
3. Roles and mechanisms of microRNAs in pancreatic cancer.
Zhang L; Jamaluddin MS; Weakley SM; Yao Q; Chen C
World J Surg; 2011 Aug; 35(8):1725-31. PubMed ID: 21222121
[TBL] [Abstract][Full Text] [Related]
4. Molecular mechanisms underlying the role of microRNAs in the chemoresistance of pancreatic cancer.
Garajová I; Le Large TY; Frampton AE; Rolfo C; Voortman J; Giovannetti E
Biomed Res Int; 2014; 2014():678401. PubMed ID: 25250326
[TBL] [Abstract][Full Text] [Related]
5. Investigating the regulatory role of miRNAs as silent conductors in the management of pathogenesis and therapeutic resistance of pancreatic cancer.
Abulsoud AI; Elshaer SS; Abdelmaksoud NM; Zaki MB; El-Mahdy HA; Ismail A; Al-Noshokaty TM; Fathi D; Abdel-Reheim MA; Mohammed OA; Doghish AS
Pathol Res Pract; 2023 Nov; 251():154855. PubMed ID: 37806169
[TBL] [Abstract][Full Text] [Related]
6. Molecular alterations contributing to pancreatic cancer chemoresistance.
Rajabpour A; Rajaei F; Teimoori-Toolabi L
Pancreatology; 2017; 17(2):310-320. PubMed ID: 28065383
[TBL] [Abstract][Full Text] [Related]
7. Downregulated miR-506 expression facilitates pancreatic cancer progression and chemoresistance via SPHK1/Akt/NF-κB signaling.
Li J; Wu H; Li W; Yin L; Guo S; Xu X; Ouyang Y; Zhao Z; Liu S; Tian Y; Tian Z; Ju J; Ni B; Wang H
Oncogene; 2016 Oct; 35(42):5501-5514. PubMed ID: 27065335
[TBL] [Abstract][Full Text] [Related]
8. Insights into the Role of microRNAs in Pancreatic Cancer Pathogenesis: Potential for Diagnosis, Prognosis, and Therapy.
Khan MA; Zubair H; Srivastava SK; Singh S; Singh AP
Adv Exp Med Biol; 2015; 889():71-87. PubMed ID: 26658997
[TBL] [Abstract][Full Text] [Related]
9. Long non-coding RNAs and tyrosine kinase-mediated drug resistance in pancreatic cancer.
Li D; Weng S; Zeng K; Xu H; Wang W; Shi J; Chen J; Chen C
Gene; 2024 Feb; 895():148007. PubMed ID: 37981080
[TBL] [Abstract][Full Text] [Related]
10. MiRNAs directly targeting the key intermediates of biological pathways in pancreatic cancer.
Sarwar A; Wang B; Su Q; Zhang Y
Biochem Pharmacol; 2021 Jul; 189():114357. PubMed ID: 33279497
[TBL] [Abstract][Full Text] [Related]
11. The MiR-135b-BMAL1-YY1 loop disturbs pancreatic clockwork to promote tumourigenesis and chemoresistance.
Jiang W; Zhao S; Shen J; Guo L; Sun Y; Zhu Y; Ma Z; Zhang X; Hu Y; Xiao W; Li K; Li S; Zhou L; Huang L; Lu Z; Feng Y; Xiao J; Zhang EE; Yang L; Wan R
Cell Death Dis; 2018 Feb; 9(2):149. PubMed ID: 29396463
[TBL] [Abstract][Full Text] [Related]
12. Identification of miR-601 as a novel regulator in the development of pancreatic cancer.
Cao W; Jin H; Zhang L; Chen X; Qian H
Biochem Biophys Res Commun; 2017 Jan; 483(1):638-644. PubMed ID: 27993677
[TBL] [Abstract][Full Text] [Related]
13. Integrative microRNA and gene expression analysis identifies new epigenetically regulated microRNAs mediating taxane resistance in ovarian cancer.
Hassan MK; Waly AA; Elsayed W; Keshk S; Allam WR; El-Khamisy SF
Sci Rep; 2021 Jan; 11(1):562. PubMed ID: 33436648
[TBL] [Abstract][Full Text] [Related]
14. Upregulation of miR-181c contributes to chemoresistance in pancreatic cancer by inactivating the Hippo signaling pathway.
Chen M; Wang M; Xu S; Guo X; Jiang J
Oncotarget; 2015 Dec; 6(42):44466-79. PubMed ID: 26561204
[TBL] [Abstract][Full Text] [Related]
15. MicroRNAs and colorectal cancer chemoresistance: New solution for old problem.
Vaghari-Tabari M; Majidinia M; Moein S; Qujeq D; Asemi Z; Alemi F; Mohamadzadeh R; Targhazeh N; Safa A; Yousefi B
Life Sci; 2020 Oct; 259():118255. PubMed ID: 32818543
[TBL] [Abstract][Full Text] [Related]
16. The Role of MicroRNAs in the Chemoresistance of Breast Cancer.
Wang J; Yang M; Li Y; Han B
Drug Dev Res; 2015 Nov; 76(7):368-74. PubMed ID: 26310899
[TBL] [Abstract][Full Text] [Related]
17. A miR-146a-5p/TRAF6/NF-kB p65 axis regulates pancreatic cancer chemoresistance: functional validation and clinical significance.
Meng Q; Liang C; Hua J; Zhang B; Liu J; Zhang Y; Wei M; Yu X; Xu J; Shi S
Theranostics; 2020; 10(9):3967-3979. PubMed ID: 32226532
[No Abstract] [Full Text] [Related]
18. The Role of MicroRNAs in Resistance to Current Pancreatic Cancer Treatment: Translational Studies and Basic Protocols for Extraction and PCR Analysis.
Garajová I; Le Large TY; Giovannetti E; Kazemier G; Biasco G; Peters GJ
Methods Mol Biol; 2016; 1395():163-87. PubMed ID: 26910074
[TBL] [Abstract][Full Text] [Related]
19. miR-92b-3p acts as a tumor suppressor by targeting Gabra3 in pancreatic cancer.
Long M; Zhan M; Xu S; Yang R; Chen W; Zhang S; Shi Y; He Q; Mohan M; Liu Q; Wang J
Mol Cancer; 2017 Oct; 16(1):167. PubMed ID: 29078789
[TBL] [Abstract][Full Text] [Related]
20. Pancreatic cancer and oligonucleotide therapy: Exploring novel therapeutic options and targeting chemoresistance.
Papaefthymiou A; Doukatas A; Galanopoulos M
Clin Res Hepatol Gastroenterol; 2022 May; 46(5):101911. PubMed ID: 35346893
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
